Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
Clin Infect Dis
    September 2017
  1. MACIAS J, Mancebo M, Merino D, Tellez F, et al
    Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
    Clin Infect Dis. 2017;65:1012-1019.
    >> Share

  2. TRICKEY A, May MT, Schommers P, Tate J, et al
    CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Clin Infect Dis. 2017;65:959-966.
    >> Share

    June 2017
  3. SMITH SE, Pratt R, Trieu L, Barry PM, et al
    Epidemiology of pediatric multidrug-resistant tuberculosis in the United States, 1993-2014.
    Clin Infect Dis. 2017 Jun 19. doi: 10.1093.
    >> Share

  4. HIGDON MM, Le T, O'Brien KL, Murdoch DR, et al
    Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study.
    Clin Infect Dis. 2017;64.
    >> Share

  5. PARK DE, Baggett HC, Howie SRC, Shi Q, et al
    Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii.
    Clin Infect Dis. 2017;64.
    >> Share

  6. LOSINA E, Hyle EP, Borre ED, Linas BP, et al
    Projecting 10-yr, 20-yr and Lifetime Risks of Cardiovascular Disease in Persons Living with HIV in the US.
    Clin Infect Dis. 2017 Jun 12. doi: 10.1093.
    >> Share

  7. KOULLIAS Y, Sax PE, Fields NF, Walensky RP, et al
    Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?
    Clin Infect Dis. 2017 Jun 9. doi: 10.1093.
    >> Share

  8. SCHALKWIJK S, Colbers A, Konopnicki D, Gingelmaier A, et al
    Lowered rilpivirine exposure during third trimester of pregnancy in HIV-1-positive women.
    Clin Infect Dis. 2017 Jun 8. doi: 10.1093.
    >> Share

  9. NEL JS, Lippincott CK, Berhanu R, Spencer DC, et al
    Does disseminated nontuberculous mycobacterial disease cause false-positive Determine B-LAM lateral flow assay results? A retrospective review.
    Clin Infect Dis. 2017 Jun 2. doi: 10.1093.
    >> Share

    May 2017
  10. SANDUL AL, Nwana N, Holcombe JM, Lobato MN, et al
    High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    >> Share

  11. JAO J, Kacanek D, Williams PL, Geffner ME, et al
    Birth Weight and Preterm Delivery Outcomes of Perinatally vs. non-Perinatally HIV-infected Pregnant Women in the U.S.: Results from the PHACS SMARTT Study and IMPAACT P1025 Protocol.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    >> Share

  12. FEARNHILL E, Gourlay A, Malyuta R, Simmons R, et al
    A Phylogenetic Analysis of HIV-1 Sequences in Kiev: Findings among Key Populations.
    Clin Infect Dis. 2017 May 29. doi: 10.1093.
    >> Share

  13. BRINKLEY-RUBINSTEIN L, Rosen DL, Christopher P, Bazerman L, et al
    Long Acting Injectable Anti-Retroviral Therapy: An Opportunity to Improve HIV Treatment and Reduce HIV Transmission among Persons being Released from Prison Facilities.
    Clin Infect Dis. 2017 May 26. doi: 10.1093.
    >> Share

  14. KUNIHOLM MH, Strickler HD, Anastos K, Prokunina-Olsson L, et al
    Relationship of Genotype for HLA B*57 and IFNL4 with Disease Progression in Female HIV Controllers.
    Clin Infect Dis. 2017 May 24. doi: 10.1093.
    >> Share

  15. PRODGER JL, Lai J, Reynolds SJ, Keruly JC, et al
    Reduced Frequency of Cells Latently Infected with Replication-Competent HIV-1 in Virally Suppressed Individuals Living in Rakai, Uganda.
    Clin Infect Dis. 2017 May 23. doi: 10.1093.
    >> Share

  16. AIBANA O, Franke MF, Huang CC, Galea JT, et al
    Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.
    Clin Infect Dis. 2017 May 20. doi: 10.1093.
    >> Share

  17. BOHLIUS J
    Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study.
    Clin Infect Dis. 2017 May 20. doi: 10.1093.
    >> Share

  18. HO EL, Maxwell CL, Dunaway SB, Sahi SK, et al
    Neurosyphilis Increases HIV-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals with Syphilis.
    Clin Infect Dis. 2017 May 19. doi: 10.1093.
    >> Share

  19. KAWKITINARONG K, Suwanpimolkul G, Kateruttanakul P, Manosuthi W, et al
    Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Clin Infect Dis. 2017;64.
    >> Share

  20. TENFORDE MW, Mokomane M, Leeme T, Patel RKK, et al
    Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    >> Share

  21. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Incidence of Gonorrhea and Chlamydia Following HIV Preexposure Prophylaxis among Men Who Have Sex with Men: A Modeling Study.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    >> Share

  22. FOLARANMI TA, Kretz CB, Kamiya H, MacNeil JR, et al
    Increased Risk for Meningococcal Disease among Men who have Sex with Men in the United States, 2012-2015.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    >> Share

  23. COLE SR, Edwards JK, Hall HI, Brookhart MA, et al
    Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States.
    Clin Infect Dis. 2017 May 12. doi: 10.1093.
    >> Share

  24. BAZAN JA, Turner AN, Kirkcaldy RD, Retchless AC, et al
    Large Cluster of Neisseria Meningitidis Urethritis in Columbus, Ohio, 2015.
    Clin Infect Dis. 2017 May 8. doi: 10.1093.
    >> Share

  25. HARAUSZ EP, Leigh J, Garcia-Prats AJ, Furin J, et al
    Stability of Second-Line Tuberculosis Medications Mixed with Milk or Yogurt.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    >> Share

  26. SOCIAS ME, Nosova E, Kerr T, Hayashi K, et al
    Patterns of transmitted drug resistance and virological response to first-line antiretroviral treatment among HIV-positive people who use illicit drugs in a Canadian setting.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    >> Share

  27. BARDENHEIER BH, McNeil MM, Wodi AP, McNicholl J, et al
    Risk of non-targeted infectious disease hospitalizations among U.S. children following inactivated and live vaccines, 2005-2014.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    >> Share

  28. SEIFERT M, Georghiou SB, Garfein RS, Catanzaro D, et al
    Impact of fluoroquinolone use on mortality among a cohort of suspected drug-resistant tuberculosis patients.
    Clin Infect Dis. 2017 May 5. doi: 10.1093.
    >> Share

  29. WALKER NF, Wilkinson KA, Meintjes G, Tezera LB, et al
    Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study.
    Clin Infect Dis. 2017 May 5. doi: 10.1093.
    >> Share

    April 2017
  30. ROSENBERG ES, Hall EW, Sullivan PS, Sanchez TH, et al
    Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
    Clin Infect Dis. 2017 Apr 26. doi: 10.1093.
    >> Share

  31. DIEPSTRA KL, Rhodes AG, Bono RS, Patel S, et al
    Comprehensive Ryan White Assistance and HIV Clinical Outcomes: Retention in Care and Viral Suppression in a Medicaid Non-Expansion State.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    >> Share

  32. LORENZ DR, Dutta A, Mukerji SS, Holman A, et al
    Marijuana use impacts midlife cardiovascular events in HIV-infected men.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    >> Share

  33. GUTIERREZ-VALENCIA A, Benmarzouk-Hidalgo OJ, Rivas-Jeremias I, Espinosa N, et al
    Viral kinetics in semen with different antiretroviral families in treatment-naive HIV-infected patients: a randomized trial.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    >> Share

  34. EATON JW, Johnson CC, Gregson S
    The cost of not re-testing: HIV misdiagnosis in the ART 'test-and-offer' era.
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    >> Share

  35. LAZAR R, Kersanske L, Xia Q, Daskalakis D, et al
    Hospitalization rates among people with HIV/AIDS in New York City, 2013.
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    >> Share

  36. DAVIS NL, Wiener J, Juliano JJ, Adair L, et al
    Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study.
    Clin Infect Dis. 2017 Apr 21. doi: 10.1093.
    >> Share

  37. MURNANE PM, Strehlau R, Shiau S, Patel F, et al
    Switching to efavirenz versus remaining on ritonavir-boosted lopinavir in HIV-infected children exposed to nevirapine: long-term outcomes of a randomized trial.
    Clin Infect Dis. 2017 Apr 17. doi: 10.1093.
    >> Share

  38. EATON EF, Gravett RM, Tamhane AR, Mugavero MJ, et al
    Antiretroviral Therapy Initiation and Changes in Self-Reported Depression.
    Clin Infect Dis. 2017 Apr 15. doi: 10.1093.
    >> Share

  39. CHOW EPF, Callander D, Fairley CK, Zhang L, et al
    Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis.
    Clin Infect Dis. 2017 Apr 13. doi: 10.1093.
    >> Share

  40. GUARALDI G, Rockwood K
    Geriatric-HIV medicine is born.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    >> Share

  41. UNDERWOOD J, Cole JH, Caan M, De Francesco D, et al
    Grey and white matter abnormalities in treated HIV-disease and their relationship to cognitive function.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    >> Share

  42. WALENSKY RP, Del Rio C, Armstrong WS
    Charting the Future of Infectious Disease: Anticipating and Addressing the Supply and Demand Mismatch.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    >> Share

  43. SINGH HK, Del Carmen T, Freeman R, Glesby MJ, et al
    From One Syndrome to Many: Incorporating Geriatric Consultation into HIV Care.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    >> Share

  44. ADAORA A A, Cole SR, Eron JJ
    US Black Women and HIV Prevention: Time for New Approaches to Clinical Trials.
    Clin Infect Dis. 2017 Apr 5. doi: 10.1093.
    >> Share

  45. QIN Q, Guo W, Tang W, Mahapatra T, et al
    Spatial Analysis of the Human Immunodeficiency Virus Epidemic among Men Who Have Sex with Men in China, 2006-2015.
    Clin Infect Dis. 2017;64:956-963.
    >> Share

  46. MORRIS MD, Shiboski S, Bruneau J, Hahn JA, et al
    Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.
    Clin Infect Dis. 2017;64:860-869.
    >> Share

  47. SUNGKANUPARPH S, Savetamornkul C, Pattanapongpaiboon W
    Primary Prophylaxis for Cryptococcosis With Fluconazole in Human Immunodeficiency Virus-Infected Patients With CD4 T-Cell Counts <100 Cells/microL and Receiving Antiretroviral Therapy.
    Clin Infect Dis. 2017;64:967-970.
    >> Share

  48. BROGER T, Basu Roy R, Filomena A, Greef CH, et al
    Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.
    Clin Infect Dis. 2017;64:947-955.
    >> Share

  49. NOSKA AJ, Belperio PS, Loomis TP, O'Toole TP, et al
    Prevalence of HIV, HCV and HBV among Homeless and Non-homeless United States Veterans.
    Clin Infect Dis. 2017 Apr 1. doi: 10.1093.
    >> Share

    March 2017
  50. WYLES D, Brau N, Kottilil S, Daar ES, et al
    Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study.
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    >> Share

  51. JOHS NA, Wu K, Tassiopoulos K, Koletar SL, et al
    Disability among Middle-Aged and Older Persons with HIV Infection.
    Clin Infect Dis. 2017 Mar 27. doi: 10.1093.
    >> Share

  52. SOHN AH, Hazra R
    Old Problems for New Providers: Managing the Postpediatric HIV Generation.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    >> Share

  53. JANSSEN S, Schutz C, Ward A, Nemes E, et al
    Mortality in Severe HIV-TB Associates with Innate Immune Activation and Dysfunction of Monocytes.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    >> Share

  54. BECOFSKY K, Wing EJ, McCaffery J, Bodreau M, et al
    A Randomized, Controlled Trial of a Behavioral Weight Loss Program for HIV-Infected Patients.
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    >> Share

  55. HWANG C, Schurmann D, Sobotha C, Boffito M, et al
    Antiviral Activity, Safety, and Exposure-Response relationships of GSK3532795, a Second-Generation HIV-1 Maturation Inhibitor, administered as Monotherapy or in Combination with Atazanavir+/-Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    >> Share

  56. BUTT AA, Ren Y, Lo Re V 3rd, Taddei T, et al
    Comparing Child-Pugh, MELD and FIB-4 to Predict Clinical Outcomes in HCV-Infected Persons: Results from ERCHIVES.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    >> Share

  57. ADACHI K, Xu J, Ank B, Watts DH, et al
    Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    >> Share

  58. MADHI SA, Nunes M, Weinberg A, Kuwanda L, et al
    Contribution of serology assays in the evaluation of influenza virus infection rates and vaccine efficacy in pregnant women: Report from randomized controlled trials.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    >> Share

  59. THOMAS M, Hopkins C, Duffy E, Lee D, et al
    Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    >> Share

  60. CURLIN ME, Gvetadze R, Leelawiwat W, Martin M, et al
    Analysis of false-negative HIV rapid tests performed on oral fluid in three international clinical research studies.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    >> Share

  61. GOURLAY A, Noori T, Pharris A, Axelsson M, et al
    The HIV continuum of care in European Union countries in 2013: data and challenges.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    >> Share

  62. BERSHETYN A, Odeny TA, Lyamuya R, Nakiwogga-Muwanga A, et al
    The causal effect of tracing by peer health workers on return to clinic among patients who were lost to follow-up from antiretroviral therapy in eastern Africa: a randomized "natural experiment" arising from surveillance of lost patients.
    Clin Infect Dis. 2017 Mar 17. doi: 10.1093.
    >> Share

  63. WHITE AC JR
    Treatment of Early Syphilis in HIV: What Do We Really Know?
    Clin Infect Dis. 2017;64:765-766.
    >> Share

  64. COLLIER D, Iwuji C, Derache A, de Oliveira T, et al
    Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    >> Share

  65. HERRICK JA, Legrand F, Gounoue R, Nchinda G, et al
    Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    >> Share

  66. KUGATHASAN R, Collier DA, Haddow LJ, El Bouzidi K, et al
    Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    >> Share

  67. CEPEDA JA, Thomas DL, Astemborski J, Sulkowski MS, et al
    Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    >> Share

  68. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  69. CYKTOR JC, Mellors JW
    TLR Agonists: Can They Exact a Toll on HIV Persistence?
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  70. VIBHOLM L, Schleimann MH, Hojen JF, Benfield T, et al
    Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  71. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  72. UPRETY P, Patel K, Karalius B, Ziemniak C, et al
    HIV-1 DNA Decay Dynamics with Early, Long-term Virologic Control of Perinatal Infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  73. PARKER RA, Rabideau DJ, Sax PE, Tierney C, et al
    The Impact of Medication Adherence on Virologic Failure in A5202, A Randomized, Partially-Blinded, Phase 3B Study.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    >> Share

  74. NEGOESCU DM, Zhang Z, Bucher HC, Bendavid E, et al
    Differentiated HIV Rna Viral Load Monitoring in Resource Limited Settings: An Economic Analysis.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    >> Share

    February 2017
  75. NAGGIE S, Marks KM, Hughes M, Fierer DS, et al
    Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
    Clin Infect Dis. 2017 Feb 27. doi: 10.1093.
    >> Share

  76. LAKE JE, Stanley T, Apovian C, Bhasin S, et al
    Practical Review of Recognition and Management of Obesity and Lipohypertrophy in HIV Infection.
    Clin Infect Dis. 2017 Feb 24. doi: 10.1093.
    >> Share

  77. BORGES AH, Hoy J, Florence E, Sedlacek D, et al
    Antiretrovirals, fractures and osteonecrosis in a large international HIV cohort.
    Clin Infect Dis. 2017 Feb 22. doi: 10.1093.
    >> Share

  78. ELUL B, Saito S, Chung H, Hoos D, et al
    Attrition from HIV treatment programs in Africa: A longitudinal ecological analysis using data from 307,144 patients initiating antiretroviral therapy between 2005 and 2010.
    Clin Infect Dis. 2017 Feb 21. doi: 10.1093.
    >> Share

  79. RAVIMOHAN S, Tamuhla N, Nfanyana K, Ni H, et al
    Elevated pre-ART CD39+CD8+ T-cell frequency is associated with early mortality in advanced HIV/TB.
    Clin Infect Dis. 2017 Feb 16. doi: 10.1093.
    >> Share

  80. PETERS H, Francis K, Sconza R, Horn A, et al
    UK Mother-to-Child HIV Transmission Rates Continue to Decline: 2012-2014.
    Clin Infect Dis. 2017;64:527-528.
    >> Share

  81. MORRIS SR, Zhao M, Smith DM, Vargas MV, et al
    Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Clin Infect Dis. 2017;64:428-434.
    >> Share

  82. WONG C, Gange SJ, Buchacz K, Moore RD, et al
    First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013.
    Clin Infect Dis. 2017;64:459-467.
    >> Share

  83. LO RE V
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2017;64:498-500.
    >> Share

  84. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017;64:490-497.
    >> Share

  85. ANDRADE R, Rodriguez-Barradas MC, Yasukawa K, Villarreal E, et al
    Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.
    Clin Infect Dis. 2017 Feb 14. doi: 10.1093.
    >> Share

  86. FONJUNGO PN, Alemnji GA, Kebede Y, Opio A, et al
    Combatting Global Infectious Diseases: A Network Effect of Specimen Referral Systems.
    Clin Infect Dis. 2017 Feb 13. doi: 10.1093.
    >> Share

  87. CLIFFORD GM, Tully S, Franceschi S
    Carcinogenicity of human papillomavirus types in HIV-positive women: A meta-analysis from HPV infection to cervical cancer.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    >> Share

  88. YOUNG J, Rossi C, Gill J, Walmsley S, et al
    Risk factors for hepatitis C virus reinfection after sustained virologic response in patients co-infected with HIV.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    >> Share

  89. BHATTACHARYA D, Belperio PS, Shahoumian TA, Loomis TP, et al
    Effectiveness of All-Oral Antiviral Regimens in 996 Genotype 1 HIV/HCV Coinfected Patients Treated in Routine Practice.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    >> Share

  90. BURTON MJ, Naggie S
    Real World Effectiveness of DAA Therapies in HIV/HCV Co-Infection: 996 Veterans Can't Be Wrong.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    >> Share

  91. BEGUELIN C, Friolet N, Moradpour D, Sahli R, et al
    Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    >> Share

  92. BAGHI HB, Aghazadeh M, Rashedi J, Poor BM, et al
    HIV/AIDS in Iran.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    >> Share

  93. ANDREONI M, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  94. DOMINGUEZ-MOLINA B, Tarancon-Diez L, Hua S, Abad-Molina C, et al
    HLA-B*57 and IFNL4-Related Polymorphisms Are Associated With Protection Against HIV-1 Disease Progression in Controllers.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  95. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin-18 in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Coinfection Versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  96. SPEC A, Olsen MA, Raval K, Powderly WG, et al
    Impact of Infectious Diseases Consultation on Mortality of Cryptococcal Infection in Patients Without HIV.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  97. FERRANDO-MARTINEZ S, De Pablo-Bernal RS, De Luna-Romero M, De Ory SJ, et al
    Thymic function failure is associated with HIV-disease progression.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    >> Share

  98. VINIKOOR MJ, Sinkala E, Chilengi R, Mulenga L, et al
    Impact of antiretroviral therapy on liver fibrosis among HIV-infected adults with and without HBV coinfection in Zambia.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    >> Share

  99. DUGAST AS, Arnold K, Lofano G, Moore S, et al
    Virus-driven inflammation is associated with the development of bNAbs in spontaneous controllers of HIV.
    Clin Infect Dis. 2017 Feb 3. doi: 10.1093.
    >> Share

    January 2017
  100. PROANO A, Bravard MA, Lopez JW, Lee GO, et al
    Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    >> Share

  101. EL-MALLAWANY NK, Villiera J, Kamiyango W, Mhango J, et al
    Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi.
    Clin Infect Dis. 2017 Jan 11. pii: ciw879. doi: 10.1093.
    >> Share

  102. RIVERO-JUAREZ A, Frias M, Lopez-Lopez P, Risalde ML, et al
    Hepatitis E virus infection in anti-HEV IgG-carryinfing patients after successful HCV treatment: reactivation or reinfection?
    Clin Infect Dis. 2017 Jan 11. pii: cix004. doi: 10.1093.
    >> Share

  103. BANNAZADEH BAGHI H, Aghazadeh M, Rashedi J, Mahdavi Poor B, et al
    HIV/AIDS in Iran.
    Clin Infect Dis. 2017 Jan 11. pii: cix006. doi: 10.1093.
    >> Share

    December 2016
  104. SORIA A, Alteri C, Scarlatti G, Bertoli A, et al
    Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report.
    Clin Infect Dis. 2016 Dec 28. pii: ciw851. doi: 10.1093.
    >> Share

  105. PINTYE J, Drake AL, Kinuthia J, Unger JA, et al
    A risk assessment tool for identifying pregnant and postpartum women who may benefit from pre-exposure prophylaxis (PrEP).
    Clin Infect Dis. 2016 Dec 28. pii: ciw850. doi: 10.1093.
    >> Share

  106. LIN A, Ong KJ, Hobbelen P, King E, et al
    Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men.
    Clin Infect Dis. 2016 Dec 23. pii: ciw845. doi: 10.1093.
    >> Share

  107. PATEL EU, Kirkpatrick AR, Grabowski MK, Kigozi G, et al
    Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.
    Clin Infect Dis. 2016 Dec 22. pii: ciw847. doi: 10.1093.
    >> Share

  108. MASSIMO A, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2016 Dec 22. pii: ciw846. doi: 10.1093.
    >> Share

  109. DOMINGUEZ-MOLINA B, Tarancon-Diez L, Hua S, Abad-Molina C, et al
    HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
    Clin Infect Dis. 2016.
    >> Share

  110. CRANSTON RD, Lama JR, Richardson BA, Carballo-Dieguez A, et al
    MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.
    Clin Infect Dis. 2016.
    >> Share

  111. LO RE V 3RD
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2016.
    >> Share

  112. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2016.
    >> Share

  113. MATTSON CL, Bradley H, Beer L, Johnson C, et al
    Increased STD testing among sexually active persons receiving medical care for HIV infection in the United States, 2009 - 2013.
    Clin Infect Dis. 2016.
    >> Share

  114. ROJAS LJ, Salim M, Cober E, Richter SS, et al
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Clin Infect Dis. 2016.
    >> Share

  115. WONG C, Gange SJ, Buchacz K, Moore RD, et al
    First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013.
    Clin Infect Dis. 2016.
    >> Share

  116. SHIELS MS, Althoff KN, Pfeiffer RM, Achenbach CJ, et al
    HIV Infection, Immune Suppression and Age at Diagnosis of Non-AIDS-Defining Cancers.
    Clin Infect Dis. 2016.
    >> Share

  117. MAZUR NI, Bont L, Cohen AL, Cohen C, et al
    Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection with Viral Coinfection in HIV-uninfected Children.
    Clin Infect Dis. 2016.
    >> Share

  118. SPEC A, Olsen MA, Raval K, Powderly WG, et al
    Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIV.
    Clin Infect Dis. 2016.
    >> Share

  119. MORRIS SR, Zhao M, Smith DR, Vargas MV, et al
    Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Clin Infect Dis. 2016.
    >> Share

  120. WALL EC, Mukaka M, Scarborough M, Ajdukiewicz KM, et al
    Prediction of outcome from adult bacterial meningitis in a high HIV seroprevalence, resource-poor setting using the Malawi Adult Meningitis Score (MAMS).
    Clin Infect Dis. 2016.
    >> Share

  121. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2016.
    >> Share

  122. VINNARD C, King L, Munsiff S, Crossa A, et al
    The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City: A Cohort Study.
    Clin Infect Dis. 2016.
    >> Share

  123. MYER L, Dunning L, Lesosky M, Hsiao NY, et al
    Frequency of viremic episodes in HIV-infected women initiating antiretroviral therapy during pregnancy: a cohort study.
    Clin Infect Dis. 2016.
    >> Share

  124. PETERS H, Francis K, Sconza R, Horn A, et al
    UK Mother to Child HIV Transmission Rates Continue to Decline: 2012-2014.
    Clin Infect Dis. 2016.
    >> Share

  125. BARGER-KAMATE B, Deloria Knoll M, Kagucia EW, Prosperi C, et al
    Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study.
    Clin Infect Dis. 2016;63.
    >> Share

  126. NUNES MC, Downs S, Jones S, van Niekerk N, et al
    Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study.
    Clin Infect Dis. 2016;63.
    >> Share

  127. SOOFIE N, Nunes MC, Kgagudi P, van Niekerk N, et al
    The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants.
    Clin Infect Dis. 2016;63.
    >> Share

  128. GILL CJ, Mwananyanda L, MacLeod W, Kwenda G, et al
    Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Clin Infect Dis. 2016;63.
    >> Share

    November 2016
  129. HAVENS PL, Stephensen CB, Van Loan MD, Schuster GU, et al
    Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
    Clin Infect Dis. 2016 Nov 15. pii: ciw765. doi: 10.1093.
    >> Share

  130. MEIJIDE H, Mena A, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Cancer Incidence in Persons Living With HIV.
    Clin Infect Dis. 2016 Nov 14. pii: ciw759. doi: 10.1093.
    >> Share

  131. BADER J, Daumer M, Schoni-Affolter F, Boni J, et al
    Therapeutic immune recovery prevents emergence of CXCR4-tropic HIV-1.
    Clin Infect Dis. 2016.
    >> Share

  132. PANACKAL AA, Komori M, Kosa P, Khan O, et al
    Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.
    Clin Infect Dis. 2016 Nov 10. pii: ciw739. doi: 10.1093.
    >> Share

  133. GAISA M, Ita-Nagy F, Sigel K, Arens Y, et al
    High Rates of Anal High-Grade Squamous Intraepithelial Lesions in HIV-Infected Women Who Do Not Meet Screening Guidelines.
    Clin Infect Dis. 2016.
    >> Share

  134. FOSTER AL, Gaisa MM, Hijdra RM, Turner SS, et al
    Shedding of Hepatitis C Virus Into the Rectum of HIV-infected Men Who Have Sex With Men.
    Clin Infect Dis. 2016 Nov 9. pii: ciw740. doi: 10.1093.
    >> Share

    October 2016
  135. BHARTI AR, McCutchan A, Deutsch R, Smith DM, et al
    Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.
    Clin Infect Dis. 2016.
    >> Share

  136. PELOQUIN CA, Dorman SE, Vernon A, Battista Migliori G, et al
    Reply to Alffenaar et al.
    Clin Infect Dis. 2016.
    >> Share

  137. HUNT PW
    Very Early ART and Persistent Inflammation in Treated HIV.
    Clin Infect Dis. 2016.
    >> Share

  138. ROSADO-SANCHEZ I, Herrero-Fernandez I, Genebat M, Ruiz-Mateos E, et al
    Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
    Clin Infect Dis. 2016.
    >> Share

  139. WU H, Mendoza MC, Huang YA, Hayes T, et al
    Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.
    Clin Infect Dis. 2016.
    >> Share

  140. RUSSELL K, Hills SL, Oster AM, Porse CC, et al
    Male-to-Female Sexual Transmission of Zika Virus-United States, January-April 2016.
    Clin Infect Dis. 2016.
    >> Share

  141. SAINZ T, Navarro ML
    HIV-Infected Youths: Transition in Spain Compared to the Netherlands.
    Clin Infect Dis. 2016.
    >> Share

  142. GOLDSCHMIDT RH
    Preexposure Prophylaxis in the United States: An Evolving HIV Prevention Opportunity.
    Clin Infect Dis. 2016.
    >> Share

  143. DELANEY KP, Hanson DL, Masciotra S, Ethridge SF, et al
    Time until emergence of HIV test reactivity following infection with HIV-1: Implications for interpreting test results and retesting after exposure.
    Clin Infect Dis. 2016.
    >> Share

  144. SERETI I, Krebs SJ, Phanuphak N, Fletcher JL, et al
    Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation.
    Clin Infect Dis. 2016.
    >> Share

  145. BROWN L, Langelier C, Reid MJ, Rutishauser RL, et al
    Antimicrobial Resistance: A Call to Action!
    Clin Infect Dis. 2016.
    >> Share

  146. NAHID P, Dorman SE, Alipanah N, Barry PM, et al
    Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
    Clin Infect Dis. 2016;63:853-67.
    >> Share

    September 2016
  147. COHEN M, Eshleman S, McCauley M, Chen Y, et al
    Antiretroviral therapy to prevent HIV acquisition: Limits of estimation from a population cohort.
    Clin Infect Dis. 2016.
    >> Share

  148. SELHORST P, Masson L, Ismail SD, Samsunder N, et al
    CErvicovaginal inflaMmation Facilitates Acquisition of less infectious HIV variants.
    Clin Infect Dis. 2016.
    >> Share

  149. LJUNGMAN P, Boeckh M, Hirsch HH, Josephson F, et al
    Definitions of CMV infection and disease in transplant patients for use in clinical trials.
    Clin Infect Dis. 2016.
    >> Share

  150. NAGGIE S, Holland D, Sulkowski MS, Thomas DL, et al
    HCV post-exposure prophylaxis in the healthcare worker: Why DAAs don't change a thing.
    Clin Infect Dis. 2016.
    >> Share

  151. BORDONI V, Sacchi A, Cimini E, Casetti R, et al
    Different Role of IL-7 and IL-18 in Affecting Lymphoid Hematopoietic Progenitor Cells and CD4 Homeostasis in Naive Primary and Chronic HIV-Infected patients.
    Clin Infect Dis. 2016.
    >> Share

  152. BROCK JB, Mena LA
    HIV Medicine Residency Training Correspondence.
    Clin Infect Dis. 2016.
    >> Share

  153. BOERMA RS, Boender TS, Bussink AP, Calis JC, et al
    Suboptimal viral suppression rates among HIV-infected children in low- and middle-income countries: a meta-analysis.
    Clin Infect Dis. 2016.
    >> Share

  154. CASTILLO-MANCILLA JR, Brown TT, Erlandson KM, Palella FJ Jr, et al
    Suboptimal cART Adherence is Associated with Higher Levels of Inflammation Despite HIV Suppression.
    Clin Infect Dis. 2016.
    >> Share

  155. THOMPSON-PAUL AM, Lichtenstein KA, Armon C, Palella FJ Jr, et al
    Cardiovascular disease risk prediction in the HIV Outpatient Study.
    Clin Infect Dis. 2016.
    >> Share

  156. BORGES AH, Neuhaus J, Babiker AG, Henry K, et al
    Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection.
    Clin Infect Dis. 2016.
    >> Share

  157. SMITH DM, Nakazawa M, Freeman ML, Anderson CM, et al
    Asymptomatic CMV Replication during Early HIV-infection is Associated with Lower CD4/CD8 Ratio during HIV Treatment.
    Clin Infect Dis. 2016.
    >> Share

    August 2016
  158. JUDD A, Le Prevost M, Melvin D, Arenas-Pinto A, et al
    Cognitive function in young people with and without perinatal HIV in the AALPHI cohort in England: the role of non-HIV related factors.
    Clin Infect Dis. 2016.
    >> Share


  159. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
    Clin Infect Dis. 2016.
    >> Share

  160. TINCATI C, Rainone V, Comi L, Pandolfo A, et al
    Cell-Mediated Immunity in HIV-Infected Males with HPV-Related Anal Dysplastic Lesions.
    Clin Infect Dis. 2016.
    >> Share

  161. JOHNSON G, Levison J, Malek J
    Should providers discuss breastfeeding with women living with HIV in high-income countries? An ethical analysis.
    Clin Infect Dis. 2016.
    >> Share

  162. TAO G, Hoover KW, Nye MB, Peters P, et al
    Rectal infection with Neisseria gonorrhoeae and Chlamydia trachomatis in males in the United States.
    Clin Infect Dis. 2016.
    >> Share

  163. DRABO EF, Hay JW, Vardavas R, Wagner ZR, et al
    A Cost-Effectiveness Analysis Of Pre-Exposure Prophylaxis For The Prevention Of HIV Among Los Angeles County Men Who Have Sex With Men.
    Clin Infect Dis. 2016.
    >> Share

  164. MAYER KH, Krakower DS
    Can We Afford to Control the HIV Epidemic with Antiretrovirals? Can We Afford Not to Do So?
    Clin Infect Dis. 2016.
    >> Share

  165. GREBELY J, Mauss S, Brown A, Bronowicki JP, et al
    Efficacy and safety of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic HCV genotype 1 infection receiving opioid substitution therapy: Analysis of Phase 3 ION trials.
    Clin Infect Dis. 2016.
    >> Share

  166. POTARD V, Simon A, Lacombe JM, Parienti JJ, et al
    Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4).
    Clin Infect Dis. 2016.
    >> Share

  167. SALINAS JL, Rentsch C, Marconi VC, Tate J, et al
    Baseline, Time-updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.
    Clin Infect Dis. 2016.
    >> Share


  168. Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: Collaborative analysis of 21 European cohort studies.
    Clin Infect Dis. 2016.
    >> Share

  169. INGILIZ P, Christensen S, Kimhofer T, Hueppe D, et al
    Sofosbuvir and Ledipasvir for 8 weeks for the treatment of chronic hepatitis C virus infection in HCV-mono-infected and HIV-HCV co-infected individuals - Results from the German hepatitis C cohort (GECCO-01).
    Clin Infect Dis. 2016.
    >> Share

  170. NAHID P, Dorman SE, Alipanah N, Barry PM, et al
    Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
    Clin Infect Dis. 2016.
    >> Share

  171. WITTKOP L
    Endstage liver disease in HIV infection: an avoidable burden?
    Clin Infect Dis. 2016.
    >> Share

  172. KLEIN MB, Althoff KN, Jing Y, Lau B, et al
    Risk of endstage liver disease in HIV-viral hepatitis co-infected persons in North America from the early to modern antiretroviral therapy eras.
    Clin Infect Dis. 2016.
    >> Share

  173. ABRAVANEL F, Metivier S, Chauveau M, Peron JM, et al
    Transmission of HCV NS5A inhibitor-resistant variants among HIV-infected men who have sex with men.
    Clin Infect Dis. 2016.
    >> Share

  174. KAMSTRA R, Azoulay L, Steele R, Klein MB, et al
    Hospitalizations in immigrants and non-immigrants diagnosed with chronic hepatitis C infection in Quebec.
    Clin Infect Dis. 2016.
    >> Share

    July 2016
  175. BOETTIGER DC, Muktiarti D, Kurniati N, Truong KH, et al
    Early height and weight changes in children using cotrimoxazole prophylaxis with antiretroviral therapy.
    Clin Infect Dis. 2016.
    >> Share

  176. HAAS AD, Msukwa MT, Egger M, Tenthani L, et al
    Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's "Option B+" programme.
    Clin Infect Dis. 2016.
    >> Share

  177. MUKERJI SS, Locascio JJ, Misra V, Lorenz DR, et al
    Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy.
    Clin Infect Dis. 2016.
    >> Share

  178. HANNA DB, Ramaswamy C, Kaplan RC, Kizer JR, et al
    Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001-2012.
    Clin Infect Dis. 2016.
    >> Share

  179. WEIJSENFELD AM, Smit C, Cohen S, Wit FW, et al
    Virological and Social outcomes of HIV-infected adolescents and young adults in the Netherlands before and after transition to adult care.
    Clin Infect Dis. 2016.
    >> Share

  180. BARLOW-MOSHA L, Angelidou K, Lindsey J, Archary M, et al
    Nevirapine- vs Lopinavir/Ritonavir-based Antiretroviral Therapy in HIV-infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.
    Clin Infect Dis. 2016.
    >> Share


  181. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    Clin Infect Dis. 2016.
    >> Share

  182. WYLES DL, Sulkowski MS, Dieterich D
    Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Clin Infect Dis. 2016;63 Suppl 1:S3-S11.
    >> Share

  183. MACBRAYNE CE, Kiser JJ
    Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    Clin Infect Dis. 2016;63 Suppl 1:S12-23.
    >> Share

  184. WANGPATHARAWANIT P, Sungkanuparph S
    Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial.
    Clin Infect Dis. 2016.
    >> Share

  185. ROWAN SE, Rogers M, Bayer J, Smith L, et al
    Treatment of HCV in HIV coinfected individuals in real world clinical settings: results from two large HIV care clinics.
    Clin Infect Dis. 2016.
    >> Share

  186. AL-KINDI SG, Zidar DA, McComsey GA, Longenecker CT, et al
    Gender differences in statin prescription rate among patients living with HIV and HCV.
    Clin Infect Dis. 2016.
    >> Share

    June 2016
  187. CREPAZ N, Tang T, Marks G, Mugavero MJ, et al
    Durable Viral Suppression and Transmission Risk Potential among Persons with Diagnosed HIV Infection: United States, 2012-2013.
    Clin Infect Dis. 2016.
    >> Share

  188. WEISER J, Beer L, West BT, Duke CC, et al
    Qualifications, Demographics, Satisfaction, and Future Capacity of the HIV Care Provider Workforce in the United States, 2013-2014.
    Clin Infect Dis. 2016.
    >> Share

  189. LYKINS J, Wang K, Wheeler K, Clouser F, et al
    Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.
    Clin Infect Dis. 2016.
    >> Share

  190. WADA NI, Bream JH, Martinez-Maza O, Macatangay B, et al
    Inflammatory biomarkers predict mortality among HIV-suppressed men: a multisite prospective cohort study.
    Clin Infect Dis. 2016.
    >> Share

  191. LOW AJ, Mburu G, Welton NJ, May MT, et al
    Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: a Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2016.
    >> Share

  192. BLOCH M, Kamminga J, Jayewardene A, Bailey M, et al
    A Screening Strategy for HIV-Associated Neurocognitive Disorders (HAND) that Accurately Identifies Patients Requiring Neurological Review.
    Clin Infect Dis. 2016.
    >> Share

  193. KEATING SM, Pilcher CD, Busch MP
    Timing is Everything - Shortcomings of Current HIV Diagnostics in the Early Treatment Era.
    Clin Infect Dis. 2016.
    >> Share

  194. DE SOUZA MS, Pinyakorn S, Akapirat S, Pattanachaiwit S, et al
    Initiation of Antiretroviral Therapy during Acute HIV-1 Infection leads to A High Rate of Non-Reactive HIV Serology.
    Clin Infect Dis. 2016.
    >> Share

  195. SOGNI P, Gilbert C, Lacombe K, Piroth L, et al
    All-oral DAA regimens in HIV-HCV coinfected cirrhotic patients are efficient and safe. Real-life results from the prospective ANRS CO13 - HEPAVIH cohort.
    Clin Infect Dis. 2016.
    >> Share

  196. ISA SE, Oche AO, Kang'ombe AR, Okopi JA, et al
    HIV and risk of type 2 diabetes in a large adult cohort in Jos, Nigeria.
    Clin Infect Dis. 2016.
    >> Share

  197. KASSAYE SG, Grossman Z, Balamane M, Johnston-White B, et al
    Transmitted HIV Drug Resistance High and Longstanding in Metropolitan Washington, D.C.
    Clin Infect Dis. 2016.
    >> Share

  198. GJAERDE LI, Shepherd L, Jablonowska E, Lazzarin A, et al
    Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus co-infected individuals from 2001 to 2014: a multi-cohort study.
    Clin Infect Dis. 2016.
    >> Share

  199. SCOTT C, Cavanaugh JS, Pratt R, Silk BJ, et al
    Human tuberculosis caused by Mycobacterium bovis in the United States, 2006-2013.
    Clin Infect Dis. 2016.
    >> Share

  200. HOOTS BE, Finlayson T, Nerlander L, Paz-Bailey G, et al
    Willingness to Take, Use of, and Indications for Pre-Exposure Prophylaxis among Men Who Have Sex with Men - 20 U.S. Cities, 2014.
    Clin Infect Dis. 2016.
    >> Share

  201. HEIDARY M, Nasiri MJ, Goudarzi M
    Why the HIV/AIDS prevalence was increased in Iran, despite the decreasing in the USA?
    Clin Infect Dis. 2016.
    >> Share

    May 2016
  202. COOPER C, Naggie S, Saag M, Yang JC, et al
    Successful Retreatment of HCV in Patients Coinfected with HIV Who Failed 12 Weeks of Ledipasvir/Sofosbuvir.
    Clin Infect Dis. 2016.
    >> Share

  203. KELLY EM, Dodge JL, Sarkar M, French AL, et al
    Marijuana Use is not Associated with Progression to Advanced Liver Fibrosis in HIV/HCV Coinfected Women.
    Clin Infect Dis. 2016.
    >> Share

  204. GIORDANO TP, Cully J, Amico KR, Davila JA, et al
    A randomized trial to test a peer mentor intervention to improve outcomes in persons hospitalized with HIV infection.
    Clin Infect Dis. 2016.
    >> Share

  205. OLDENBURG CE, Barnighausen T, Tanser F, Iwuji CC, et al
    Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa.
    Clin Infect Dis. 2016.
    >> Share

  206. MARQUINE MJ, Montoya JL, Umlauf A, Fazeli PL, et al
    The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.
    Clin Infect Dis. 2016.
    >> Share

  207. OFOTOKUN I, Titanji K, Lahiri CD, Vunnava A, et al
    A Single Dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-Induced Bone Loss in Treatment-naive HIV-infected Patients: a Phase IIb Trial.
    Clin Infect Dis. 2016.
    >> Share

  208. GLAUBIUS RL, Hood G, Penrose KJ, Parikh UM, et al
    Cost-Effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
    Clin Infect Dis. 2016.
    >> Share

  209. MEHTA SR, Murrell B, Anderson CM, Kosakovsky Pond SL, et al
    Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California.
    Clin Infect Dis. 2016.
    >> Share

  210. REIDY W, Agarwal M, Chege D, Lamb M, et al
    Retention in Care Among HIV-Infected Patients on Antiretroviral Therapy and Among Those Not on Antiretroviral Therapy in Eastern Africa.
    Clin Infect Dis. 2016.
    >> Share

  211. TUCKER JD, Cao B, Li H, Tang S, et al
    Social Media Interventions to Promote HIV Testing.
    Clin Infect Dis. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016